Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2007
12/19/2007EP1539713B1 Pyrimidine derivatives as modulators of chemokine receptor activity
12/19/2007EP1497261B1 Phenethanolamine derivatives
12/19/2007EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/19/2007EP1470122B1 Rho-kinase inhibitors
12/19/2007EP1465875B1 Novel alkansulfonamides as endothelin antagonists
12/19/2007EP1408949B1 Glycine betaine and its use as anti-hemorrhagic agent
12/19/2007EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes
12/19/2007EP1370521B1 Formanilide derivatives as beta2-adrenoreceptor agonists
12/19/2007EP1353694B1 Combinations of ezetimibe with aspirine for treating vascular conditions
12/19/2007EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
12/19/2007EP1303599B1 Methylated nucleotide regulation of upa gene expression
12/19/2007EP1292596B1 1,3,8-triaza-spiro¬4,5 decan-4-one derivatives as neurokinin receptor antagonists
12/19/2007EP1115693B9 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
12/19/2007EP1091757B1 Alpha emitting constructs and uses thereof
12/19/2007EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007EP1005341B1 Il-8 receptor antagonists
12/19/2007EP0934337B1 A process for purifying apolipoprotein a or apolipoprotein e from human plasma
12/19/2007EP0804440B1 Tricyclic benzazepine vasopressin antagonists
12/19/2007CN101088550A Medicine micropill and its prepn process
12/19/2007CN101088549A Chinese medicine prepn for treating arrhythmia and its prepn process and quality control method
12/19/2007CN101088548A Chinese medicine prepn for treating arrhythmia and its prepn process and quality control method
12/19/2007CN101088547A Application of Yin-nourishing medicine in preparing gene medicine for regulating vascular endothelial cell
12/19/2007CN101088546A Heart-benefiting Yixinshu micropill and its prepn process
12/19/2007CN101088542A Compound Chinese medicine prepn for treating chest obstruction
12/19/2007CN101088532A Chinese medicine prepn for treating apoplexy and chest obstruction and its prepn process and quality control method
12/19/2007CN101088522A Chinese medicine composition containing red sage, notoginseng and musk or muskone and its prepn
12/19/2007CN101088521A Astragalus medicine prepn and its prepn process
12/19/2007CN101088507A Application of ophiopogoni D in preparing gene medicine for regulating vasular endothelial cell period
12/19/2007CN101088506A Application of ophiopogonin D in preparing gene medicine for regulating vascular endothelial cell fucntion
12/19/2007CN101088505A Nanometer breviscapine polymer particle prepn and its prepn process
12/19/2007CN101088503A Freeze dried nimodipine powder for injection and its prepn
12/19/2007CN101088493A Nanometer alprosadil particle and its prepn process
12/19/2007CN100355903C Process for preparing oligomeric peptide capable of inhibiting angiotonase activity
12/19/2007CN100355882C Hybridoma cell strain and its produced human VEGFR-3 resistant monoclonal antibody
12/19/2007CN100355753C Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds
12/19/2007CN100355751C 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders
12/19/2007CN100355731C Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof
12/19/2007CN100355714C Arylpiperazines having 5-hydroxyl-typtamine activity
12/19/2007CN100355434C Medicine for preventing and treating cardiovascular and cerebrovascular diseases
12/19/2007CN100355426C Disodium adenosine triphosphate solid composition for injection and its preparing method
12/19/2007CN100355423C Combination comprising a vasculostatic compound and an alkylating agent for the treatmemt of a tumor
12/19/2007CN100355415C Frozen dry powder injection of astrogalus root and its preparing method
12/18/2007US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
12/18/2007US7309788 a selective N-alkylation reaction by adding a base; hydrolysing and amidating; useful for treating cardiovascular diseases caused by binding angiotensin II to its receptors, through antagonistic activity against angiotensin II receptors
12/18/2007US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists
12/18/2007US7309702 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease
12/18/2007US7309693 Comprises antagonistic mutein of MCP-1 (monocyte chemoattractant protein-1: macrophage chemotactic factor)
12/18/2007US7309604 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
12/18/2007CA2416754C Cardiac arrest fluid
12/18/2007CA2107476C Pharmaceutical packaging unit containing plasminogen activators for multiple bolus administration
12/13/2007WO2007142581A1 Combination product for the treatment or prevention of dyslipidaemia
12/13/2007WO2007142577A1 Pyrrolo[3,2-d]pyrimidin-4-one derivative as myeloperoxidase inhibitor
12/13/2007WO2007142576A1 2-thioxanthine derivatives acting as mpo-inhibitors
12/13/2007WO2007142369A1 Method for screening of anti-obesity agent
12/13/2007WO2007142323A1 Novel indazole derivative having spiro ring structure in side chain
12/13/2007WO2007142308A1 Nitrogen-containing heterocyclic compound and thrombopoietin receptor activator
12/13/2007WO2007142304A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME
12/13/2007WO2007142297A1 Composition for prevention/treatment of hepatic disease
12/13/2007WO2007142288A1 Treatment of ischemic disease using erythropoietin
12/13/2007WO2007142231A1 Agent for improvement in blood fluidity
12/13/2007WO2007142217A1 1-phenylpyridone derivative
12/13/2007WO2007142118A1 Composition for preventing the occurrence of cardiovascular event in multiple risk patient
12/13/2007WO2007141974A1 Nonhuman model animal of hypertension
12/13/2007WO2007141423A1 Ppar enhancing derivatives, method for preparing same and therapeutic use thereof
12/13/2007WO2007141318A1 2,5-disubstituted piperidines
12/13/2007WO2007141026A1 Use of a polyphenol in the treatment of the metabolic syndrome and endothelial dysfunction or other vascular sequellae.
12/13/2007WO2007140934A1 Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof
12/13/2007WO2007140894A1 5-aryl-substituted dihydropyridopyrimidines and dihydropyridazines and use thereof as mineral corticoid antagonists
12/13/2007WO2007140786A1 Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia
12/13/2007WO2007140525A1 A method of treatment and prophylaxis of events, conditions and diseases of the systemic vasculature an immune function to decrease cardiovascular risk and pathogenic infection
12/13/2007WO2007117982A3 Organic compounds
12/13/2007WO2007117981A3 Selective hydroxamate based mmp inhibitors
12/13/2007WO2007110730A3 Varenicline standards and impurity controls
12/13/2007WO2007105171A3 Killing of selected cells
12/13/2007WO2007075964A8 Thrombin receptor antagonists as prophylaxis to complications from cardiopulmonary surgery
12/13/2007WO2005048916A3 Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders
12/13/2007US20070287970 Method for systemic drug delivery through the nail
12/13/2007US20070287736 Diphenyl Substituted Alkanes as Flap Inhibitors
12/13/2007US20070287723 2-alkyl/aryl sulphonyl-1,2,3,4-tetrahydro-9h-pyrido (3,4-b) indole-3-carboxylic acid esters/amides useful as antithrombotic agents
12/13/2007US20070287721 Pyrazolopyridinyl pyridine
12/13/2007US20070287713 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
12/13/2007US20070287706 Certain substituted quinolones, compositions, and uses thereof
12/13/2007US20070287698 Tetrahydrobenzo(D)Azepin-2-One Derivatives and the Use Thereof for Treating Cardiovascular Diseases
12/13/2007US20070287684 Methods and compositions for treating trauma-hemorrhage using estrogen and derivatives thereof
12/13/2007US20070287671 Compositions and Methods for Promoting Myocardial and Peripheral Angiogenesis
12/13/2007US20070287670 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions
12/13/2007US20070287665 Urotensin-II agonists and antagonists
12/13/2007US20070287662 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
12/13/2007US20070287660 Chimeric metalloenzyme comprising fibrin binding domain for for use in treatment and prevention of thrombosis and cardiovascular disorders
12/13/2007US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders
12/13/2007US20070286868 Phosphorylcholine Conjugates and Corresponding Antibodies
12/13/2007US20070286861 Therapeutic antibody specific for oncostatin M for use in treatment and diagnosis of rheumatoid arthritis, juvenile onset arthritis or osteoarthritis
12/13/2007US20070286854 Diagnostics And Therapeutics For Diseases Associated With Dipeptidyl-Peptidase 1 (Dpp1)
12/13/2007US20070286853 Diagnostics and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Delta (Ppard)
12/13/2007US20070286848 Epas1 Gene Transfer to Improve Cell Therapy
12/13/2007US20070286845 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
12/13/2007US20070286805 Methods of Validating Target for Modulating Insulin Action, Screening for Modulators of Insulin Action and Therapeutic Uses Thereof
12/13/2007DE102006026585A1 Substituierte 4-Aryl-1,4-dihydro-1,6-naphthyridine und ihre Verwendung Substituted-4-aryl-1,4-dihydro-1,6-naphthyridines and their use
12/13/2007DE102006026583A1 Aryl-substituierte hetero-bicyclische Verbindungen und ihre Verwendung Aryl-substituted hetero-bicyclic compounds and their use
12/13/2007CA2660667A1 2,5-disubstituted piperidines
1 ... 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 ... 1595